Cabazitaxel 183133-96-2 Jevtana
1. Advanced Factory Building and Equipment
2. Competent technical team
3 .Strong R & D support
4,high quality products with high stability
5, Competitive price
5.Customer tailored service
Cabazitaxel | CAS 183133-96-2 | Brand:HERBLAND |
MW: 835.93 | MSDS: Avaiable | |
MF :C45H57NO14 | Sample: Avaiable | |
Category: Oncology drug | Min order: 10grams | |
Quality standard Enterprise standard | Place of Origin:China | |
Appearance | White powder | |
Introduction | is a semi-synthetic derivative of a natural taxoid.It was developed by Sanofi-Aventis and was approved by the U.S. Food and Drug Administration (FDA) for the treatment of hormone-refractory prostate cancer on June 17, 2010. It is a microtubule inhibitor, and the fourth taxane to be approved as a cancer therapy. | |
Applications | Pharmaceutical raw materials , Oncology drug |
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View